Studies by Yang et al. and Liang et al. [6, 9–12] have confirmed that GNG4 expression is significantly upregulated in colorectal cancer, which is related to prognosis [6], and may affect tumor progression through the PI3K-AKT signaling pathway (Figure 9). This evidence concerns the gene GNG4 and colorectal cancer.